Furtado, L.M., da Silveira, I.C., Carneiro, A.C.D.M., Zehuri, M.M.O.N., Carboni, S.S.C.M., Tavares-Murta, B.M. and Crema, V.O. 2017. Cetuximab has an inhibitory effect on cell motility in SCC-4 oral squamous cell carcinoma cell line. Cellular and Molecular Biology. 63, 9 (Sep. 2017), 13–17. DOI:https://doi.org/10.14715/cmb/2017.63.9.3.